Photo Credit: IANS
Beijing, Feb 21 (IANS) China has approved 16 domestically made Covid-19 vaccines for clinical trials, six of which have entered phase 3, according to the latest data from the National Medical Products Administration.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.